Probable Case of Cutaneous Anthrax with Toxic Manifestations and Fatality seen in an adolescent in Sokoto, Nigeria: A post-mortem review
Main Article Content
Keywords
Cutaneous Anthrax, Toxic, Mortality, Adolescent, Sokoto, Nigeria
Abstract
Background: Anthrax is a life-threatening zoonotic disease caused by Gram-positive, spore-forming bacterium Bacillus anthracis. It manifests as a cutaneous, gastrointestinal, and respiratory disease. The cutaneous form ranges from a self-limiting lesion to severe edematous lesions with toxemic shock. Of recent, increasing cases of anthrax have been reported in Nigeria warranting heightened surveillance. A patient with skin lesions suggestive of cutaneous anthrax and toxic manifestations is reviewed to emphasize the need for a high index of suspicion.
Case report: A 14-year-old boy presented with skin lesions of one month involving the hands, face, and legs, left lower limb swelling of two weeks, fever of 10 days, and fast breathing of five days duration. There was a positive history of contact with cattle carcasses at the abattoir. He was febrile (38.1oc), mildly pale, and mildly dehydrated, oxygen saturation was 95%. He was tachypnoeic and tachycardic with a low-volume pulse. There was extensive left lower limb swelling, a raised necrotic ulcer with a black surface on the calf, measuring 9cmx5cm with serosanguinous discharge, and another confluent vesicular lesion on the anterolateral aspect of the left leg measuring 8cmx6cm. Differential diagnoses considered were cellulitis, osteomyelitis, leishmaniasis, and malignancy.
Result, treatment & outcome: His packed cell volume was 33%, retroviral screening, and hepatitis screening were non-reactive, and erythrocyte sedimentation rate was 3mm/hr. Leg X-ray was normal. Other investigations could not be done due to financial constraints and the patient’s demise. He received intravenous (IV) fluid, IV ceftriaxone, IV metronidazole, tetanus toxoid, and antiseptic wound dressing. He succumbed to the illness 72 hours later. Anthrax was considered after the patient's demise due to the type of skin lesion and progression of the illness in line with the standard case definition.
Conclusion: Cutaneous anthrax with systemic manifestations should be considered as a probable diagnosis in patients with typical skin lesions and toxic features.
References
2. Doganay M, Demiraslan H. Human anthrax as a re-emerging disease. Recent patents on anti-infective drug discovery. 2015;10(1):10-29
3. Witkowski JA, Parish LC. The story of anthrax from antiquity to the present: A biological weapon of nature and humans. Clin Dermatol 2002; 20: 336-42.
4. Adesola RO, Okeke VC, Hamzat A, Onawola DA, Arthur JF. Unraveling the binational outbreak of anthrax in Ghana and Nigeria: an in-depth investigation of epidemiology, clinical presentations, diagnosis, and plausible recommendations toward its eradication in Africa. Bulletin of the National Research Centre. 2024;48(1):1-8
5. Shandilya J, Parai D, Choudhary HR, Kshatri JS, Padhy BK, Pradhan PM, et al. Suspected human anthrax outbreak investigation in a tribal village of Koraput, India, 2021. Public Health Chall 2023;2(4):e125
6. Aborode AT, Ojo-Akosile T, Uwah EA, Ottoho E, Ogunleye SC, Kamaldeen AB, et al. The outbreak of anthrax in Nigeria: Re-enforcing one health. New microbes and new infections 2023; 55:1-2.
7. Al-Mustapha AI, Oyewo M, Abubakar AT, Bamidele F, Ibrahim H, The RA-4-AEPD study group. The re-emergence of anthrax in Nigeria. IJID One Health 2023; 1:1-4.
8. Mogaji HO, Adewale B, Smith SI, Igumbor EU, Idemili CJ, Taylor-Robinson AW. Combatting anthrax outbreaks across Nigeria’s national land borders: need to optimize surveillance with epidemiological surveys. Infectious Diseases of Poverty 2024;13(1):1-7
9. Confirmation of Anthrax Outbreak in Nigeria. https://ncdc.gov.ng/news/491/confirmation-of-anthrax-outbreak-in-nigeria (Accessed 20th August 2024).
10. Doganay M, Dinc G, Kutmanova A, Baillie L. Human Anthrax: Update of the Diagnosis and Treatment. 2023;13(6):1056.
11. CDC. Anthrax (Bacillus anthracis) 2018 Case Definition. Last Reviewed: April 16, 2021, Source: Office of Public Health Data, Surveillance, and Technology.https://ndc.services.cdc.gov/case-definitions/anthrax-2018/#print. Last accessed 01/09/2024.
12. MoLHSA. Decree N01-2/n on Reporting of Medical and Statistical Information. Ministry of Labour, Health and Social Affairs of Georgia 2016.
13. Kasradze A, Echeverria D, Zakhashvili K, Bautista C, Heyer N, Imnadze P, Mirtskhulava V. Rates and risk factors for human cutaneous anthrax in the country of Georgia: National surveillance data, 2008-2015. PLoS One2018 Feb 7;13(2):e0192031.
14. Doganay M, Metan G, Alp E. A review of cutaneous anthrax and its outcome. Journal of Infection and Public Health 2010;3(3):98-105.
15. Yu X, Fang M, Wang S, Li Z, Cheng L, Liu Z, et al. Investigation on an outbreak of cutaneous anthrax in a county of Shandong Province, China, 2021. BMC infectious diseases. 2022;22(1):875.
16. Pertea M, Luca S, Moraru DC, Veliceasa B, Filip A, Grosu OM, et al. Upper Limb Compartment Syndrome—An Extremely Rare Life-Threatening Complication of Cutaneous Anthrax. 2024;12(6):1240
17. Doganay M, Metan G. Human Anthrax in Turkey from 1990 to 2007. Vector-Borne and Zoonotic Diseases. 2009;9(2):131-9
18. Doganay M, Bakir M, Dokmetas I. A case of cutaneous anthrax with toxaemic shock. British Journal of Dermatology 1987; 117:659-62
19. Janik E, Ceremuga M, Niemcewicz M, Bijak M. Dangerous Pathogens as a Potential Problem for Public Health. Medicina (Kaunas, Lithuania). 2020;56(11).10.3390/medicina5611059
20. Kutmanova A, Zholdoshev S, Roguski KM, Sholpanbayuulu M, Person MK, Cook R, et al. Risk Factors for Severe Cutaneous Anthrax in a Retrospective Case Series and Use of a Clinical Algorithm to Identify Likely Meningitis and Evaluate Treatment Outcomes, Kyrgyz Republic, 2005–2012. Clinical Infectious Diseases 2022;75(Supplement_3): S478-S86
21. Parai D, Pattnaik M, Choudhary HR, Padhi AK, Pattnaik S, Jena S, Sahoo SK, et al. Investigation of human anthrax outbreak in Koraput district of Odisha, India. Travel. Med. Infect. Dis 2023; 56:102659.
22. World Health Organization. Anthrax in Humans and Animals, 4th ed.; World Health Organization: Geneva, Switzerland, 2008; pp. 4–82.
23. Rumide TS, Samuel E, Oni O. Anthrax Outbreak in Nigeria: An Issue for Concern? J Infect Dis Epidemiol 2023; 9:310.